Serge Lichtsteiner

Serge Lichtenstein, Ph.D. has served as our Vice President, Research since September 2009.

From May 2009 to September 2009, Dr. Lichtenstein served as a consultant to us, and from September 2008 to April 2009, he was an independent consultant.

From November 2002 to August 2008, David Lichtenstein served successively as the Director of Molecular Biology, Director of Molecular and Cell Biology, and Director of Lead Discovery and Molecular Biology for Cytokinetics, Inc., a biotechnology company, where he was responsible for multiple functional teams in charge of generating the company's product pipeline and supporting all early stages of drug discovery efforts.

Prior to that experience, from November 1991 to November 2002, David Lichtenstein served as Associate Director and Head of Molecular Biology at Pfizer Global Research and Development, an affiliate of Pfizer Inc., where he was responsible for a team focused on providing engineered, recombinant proteins to enable target validation and lead optimization.

Lichtenstein holds numerous pending and issued patents in oncology, drug discovery technology, and protein chemistry.

Lichtenstein received a B.S. in Biology, a M.S. in Molecular Biology, and a Ph.D. in Molecular Biology, all from the University of Geneva in Switzerland.

Serge Lichtsteiner is the Vice President, Research at Kythera Biopharmaceuticals. With a background in Biotechnology, Serge Lichtsteiner has a rich history of leadership and innovation.Serge Lichtsteiner studied BS Biology at University of Geneva. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.